Broadcom, Vivos Therapeutics And 3 Stocks To Watch Heading Into Monday – Broadcom (NASDAQ:AVGO)
By Avi Kapoor Publication Date: 2026-04-06 05:33:00 With U.S. stock futures trading mixed this morning on Monday, some of the…
Tag: Therapeutics
BriaCell and Receptor.AI collaborate on AI-driven small molecule cancer therapeutics
By BriaCell Therapeutics Corp. Publication Date: 2025-11-20 12:30:00 BriaCell Therapeutics Corp. The collaboration leverages Receptor AI’s platform to develop highly…
Bluejay Therapeutics Enrolls First Patient in AZURE-2 Global Phase 3 Clinical Trial Evaluating Brelovitug (BJT-778) Compared to Hepcludex® (Bulevirtide) for Chronic Hepatitis D
AZURE-2 evaluates the efficacy and safety of brelovitug as a monotherapy compared head-to-head with Hepcludex (bulevirtide) Enrollment in AZURE-1, a global…
BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics – Business Wire
BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics Business Wire Article Source https://www.businesswire.com/news/home/20250417061472/en/BigHat-Biosciences-and-Lilly-Collaborate-to-Advance-AI-Driven-Antibody-Therapeutics
Market movers: Meta, HPE, Applied Digital, Lisata Therapeutics…
Market movers: Meta, HPE, Applied Digital, Lisata Therapeutics… Proactive financial news Article Source https://ca.proactiveinvestors.com/companies/news/1069744/market-movers-meta-hpe-applied-digital-lisata-therapeutics-1069744.html
Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
… Article Source https://www.manilatimes.net/2025/03/26/tmt-newswire/globenewswire/bluejay-therapeutics-announces-first-patient-dosed-in-azure-1-global-pivotal-clinical-trial-evaluating-brelovitug-bjt-778-as-a-monotherapy-treatment-for-chronic-hepatitis-d/2080574
ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics
ElevateBio has partnered with Amazon Web Services (AWS) to expedite the discovery and development of gene editing therapeutics using generative…
Stocks to Watch : Tesla, IBM, Microsoft, Lam Research, Cargo Therapeutics
By Connor Hart Tesla logged higher revenue in the fourth quarter. The electric-car maker’s revenue increased to $25.71 billion from…
NVIDIA Invests in Genesis Therapeutics to Advance AI-Powered Drug Development
Genesis Therapeutics, a private biotech company based in London and focused on artificial intelligence, has secured funding from NVentures, NVIDIA’s…
Stocks to Watch Monday: Trump Media, Viking Therapeutics, Nvidia, Intel – The Wall Street Journal
Stocks to Watch Monday: Trump Media, Viking Therapeutics, Nvidia, Intel The Wall Street Journal Article Source https://www.wsj.com/livecoverage/stock-market-today-dow-sp500-nasdaq-live-11-4-2024/card/stock-to-watch-monday-trump-media-viking-therapeutics-nvidia-intel-4IRkSNsNPNlblW6hcLco